Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended recombinant bacterial ghost system.

W Lubitz1, A Witte, F O Eko

  • 1Institute of Microbiology and Genetics, University of Vienna, Wien, Austria. oldfox@gem.univie.ac.at

Journal of Biotechnology
|September 16, 1999
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of chemicals demands assessment of risks rather than identification of hazards only.

Archives of toxicology·2026
Same author

β-Glucans from Saccharomyces cerevisiae as antiadhesive and immunomodulating polysaccharides against Campylobacterjejuni.

Microbial pathogenesis·2025
Same author

A prospective whole-mixture approach to assess risk of the food and chemical exposome.

Nature food·2023
Same author

Cardiovascular risk markers in patients with spinal cord injury: the Austrian wheelchair dancer study.

European journal of preventive cardiology·2023
Same author

Structural characterization of the carbohydrate and protein part of arabinogalactan protein from Basella alba stem and antiadhesive activity of polysaccharides from B. alba against Helicobacter pylori.

Fitoterapia·2022
Same author

[Structured or protocol-based dispatching programs].

Notfall & rettungsmedizin·2020
Same journal

The Effect of Reduced Graphene Oxide in Chitosan-Based Nanoparticles on the Enzymatic Properties of the Immobilized Enzyme.

Journal of biotechnology·2026
Same journal

High-level biosynthesis of gastrodin in engineered Escherichia coli.

Journal of biotechnology·2026
Same journal

From plasmid sequence to process design: A computational analysis of metabolism in the context of plasmid DNA manufacturing.

Journal of biotechnology·2026
Same journal

Development of an inducible cellobiohydrolase promoter and its application for enhancing the production of ganoderic acids in Ganoderma lingzhi.

Journal of biotechnology·2026
Same journal

Malic acid and allied exogenous chemicals induces desaturase gene expression and elevates PUFA production in marine microalgae Isochrysis sp.

Journal of biotechnology·2026
Same journal

Recombinant production of human papillomavirus type 16 E6 and E7 vaccine antigens in Chlamydomonas reinhardtii.

Journal of biotechnology·2026
See all related articles
This summary is machine-generated.

Recombinant bacterial ghosts, produced via PhiX174 gene E lysis, serve as advanced vaccine carriers. They effectively present foreign antigens and elicit strong immune responses without denaturation.

Area of Science:

  • Biotechnology
  • Vaccinology
  • Microbiology

Background:

  • Bacterial ghosts (BGs) are non-living bacterial cells used as vaccine candidates.
  • Recombinant BGs can display foreign antigens internally or externally.
  • The periplasmic space and lumen offer large capacities for antigen presentation.

Purpose of the Study:

  • To develop an extended recombinant bacterial ghost system for vaccine applications.
  • To utilize PhiX174 gene E for controlled bacterial lysis and ghost formation.
  • To explore the potential of recombinant BGs as carriers for diverse antigens and as adjuvants.

Main Methods:

  • Controlled expression of PhiX174 gene E to induce bacterial lysis.
  • Fusion of foreign proteins to anchor sequences for inner membrane attachment.

Related Experiment Videos

  • Expression of recombinant S-layer proteins carrying foreign epitopes.
  • Loading ghosts with antigens via dextran matrixes.
  • Immunization of animals with recombinant ghosts via oral, aerogenic, or parenteral routes.

    • Main Results:

    • Recombinant ghosts successfully presented foreign antigens on/in the ghost structure.
    • Immunization induced specific humoral and cellular immune responses, including mucosal immunity.
    • No denaturation of immunogenic determinants occurred, ensuring superior antigen quality.
    • Bacterial ghosts demonstrated inherent adjuvant properties and triggered immunoregulatory cytokine release.

    Conclusions:

    • The extended recombinant ghost system offers a novel strategy for developing adjuvant-free combination vaccines.
    • Recombinant BGs are versatile carriers for various antigens, maximizing presentation capacity.
    • This system overcomes limitations of traditional inactivated vaccines, providing superior immunogenicity.